Clinical trials
Withdrawn Lymphoma, B-Cell, Marginal Zone trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 3 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Masonic Cancer Center, University of Minnesota | 3 |
| Hoag Memorial Hospital Presbyterian | 2 |
| M.D. Anderson Cancer Center | 2 |
| Mayo Clinic | 2 |
| National Cancer Institute (NCI) | 2 |
| University of Medicine and Dentistry of New Jersey | 2 |
| Academic and Community Cancer Research United | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| CTI BioPharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell, Marginal Zone | 41 |
| Lymphoma, Follicular | 38 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 34 |
| Lymphoma, Mantle-Cell | 33 |
| Lymphoma, Non-Hodgkin | 26 |
| Lymphoma, Large B-Cell, Diffuse | 25 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 22 |
| Burkitt Lymphoma | 21 |
| Lymphoma | 21 |
| Lymphoma, Large-Cell, Immunoblastic | 19 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.